FAPi-46 GA-68 for squamous cell carcinoma of head and neck

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 27 Jan 2025: Trial registered, NCT06794372
  2. 23 Jun 2025: Trial started, NCT06794372

The trials

NCT06794372: [68Ga]Ga-FAPI-46 in Staging of Head and Neck Carcinomas

State
Under way
Phase
Phase 2
People
20 planned
Started
23 Jun 2025
Primary completion
Oct 2026
Arms
HNSCC patients
Results
None posted
  1. 27 Jan 2025: Trial registered
  2. 23 Jun 2025: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Also known as [68Ga]Ga-FAPI-46, [68Ga]Ga-FAPI-46 PET/CT.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.